全球標準試劑市場：市場規模和份額分析（按技術、應用和方法）、工業需求預測（截至2030年）

市場概況

預計2023年全球標準試劑市場規模將達到16.189億美元，2024年至2030年複合年增長率為7.0%，2030年將達25.881億美元。 研究工作的標準是材料或化學品必須超過才能進一步使用的特定要求。 這些是“參考化合物”，對於確定分析物、確定未知物和品質保證測試至關重要。

在製藥和生命科學領域，隨著臨床試驗的增加，對分析化學品的需求也在增加。 例如，此類濃縮化合物可用於分析藥物的化學和物理穩定性。

此外，生物製藥領域在全球成長最快的標準試劑市場中佔有重要地位。 標準試劑用途廣泛，從測定和生物標記開發到實驗室製造和測試，再到微量物質鑑定和純度評估。

主要考慮因素

到 2023 年，色譜的行業份額為 25%，預計在預測期內將出現顯著發展。

北美地區是標準試劑的主要市場，預測期內複合年增長率為7.2%。

該地區從當地工業、出口監管合規性以及該地區的高研發投資中受益匪淺。

本報告分析了全球標準試劑市場，包括市場的基本結構和最新情況、主要促進和抑制因素以及全球、按地區和主要國家的市場規模前景（以貨幣形式計算） ，（2017-2030） ，按技術、應用和方法劃分的詳細趨勢，當前市場競爭狀況以及主要公司概況。

目錄

第1章研究範圍

第2章研究方法

第 3 章執行摘要

第 4 章市場指標

第5章產業展望

• 市場動態
  • 趨勢
  • 促進因素
  • 抑制因素/挑戰
  • 促進/抑制因子影響分析
• 新型冠狀病毒感染 (COVID-19) 的影響
• 波特五力分析

第6章世界市場

• 摘要
• 市場收入：依技術劃分（2017-2030 年）
• 市場收入：依應用分類（2017-2030 年）
• 市場報酬：依方法劃分（2017-2030 年）
• 市場收入：按地區劃分（2017-2030 年）

第7章北美市場

• 摘要
• 市場收入：依技術劃分（2017-2030 年）
• 市場收入：依應用分類（2017-2030 年）
• 市場報酬：依方法劃分（2017-2030 年）
• 市場收入：依國家/地區劃分（2017-2030 年）

第8章歐洲市場

第9章亞太市場

第10章拉丁美洲市場

第11章中東及非洲市場

第12章美國市場

• 摘要
• 市場收入：依技術劃分（2017-2030 年）
• 市場收入：依應用分類（2017-2030 年）
• 市場報酬：依方法劃分（2017-2030 年）

第13章加拿大市場

第14章德國市場

第15章法國市場

第16章英國市場

第17章義大利市場

第18章西班牙市場

第19章日本市場

第20章中國市場

第21章印度市場

第22章澳洲市場

第23章韓國市場

第24章巴西市場

第25章墨西哥市場

第26章沙烏地阿拉伯市場

第27章南非市場

第 28 章阿聯酋 (UAE) 市場

第29章競爭態勢

• 市場參與者及其提供的產品/服務的列表
• 主要公司的競爭基準
• 各大公司的產品基準
• 近期策略發展狀況

第30章公司簡介

• Merck KGaA
• Agilent Technologies Inc.
• Waters Corporation
• LGC Standards Ltd.
• PerkinElmer Inc.
• SPEX CertiPrep
• AccuStandard Inc.
• Thermo Fisher Scientific Inc.

第31章 附錄

Market Overview

The analytical standards market size stood at USD 1,618.9 million in 2023, and it is expected to grow at a CAGR of 7.0% during 2024-2030, to reach USD 2,588.1 million by 2030. The standards for analytical work are the specific requirements that a material or chemical must exceed to be used further. They are 'reference compounds'; and they are vital in the determination of analytes, determination of unknown substances, and quality assurance testing.

The global market is providing the opportunity to launch products with high commercial viability in pharmaceutical and biotechnology, food safety and quality assurance, environmental analysis, forensics, and many other applications.

The necessity of analytical chemicals is more felt in the pharmaceutical and life sciences sector because of the increasing number of clinical trials. Such concentrated compounds are used to analyze the chemical and physical stability, for instance, of drugs.

As a result, the growing incidence of different diseases that drive drug R&D is projected to bring about a CAGR of 7.3% in the global pharmaceutical and life sciences sector in terms of the forecast period.

Additionally, the biopharmaceutical sector holds the position of the fastest-growing analytical standards marketplace in the world. The analytical standard compounds find a wide range of applications from developing assays and various biomarkers to their production and testing in the labs and the trace material identification and purity assessment.

Key Insights

In 2023, the chromatography category had a substantial industry share of 25% and is projected to witness significant development in the projection period.

Development is propelled by augmented research and development activities in drugs and biopharmaceuticals, along with technical improvements.

Chromatography plays an important role in noticing and separating chemical constituents, monitoring ecologies, studying distant galaxies, advancing medication effectiveness, and characterizing proteins.

The category's improvement is boosted by the increasing populace affected by chronic illnesses, leading to augmented demand for medications.

The North American region is the dominating industry for analytical standards, with an anticipated CAGR of 7.2% during the projection period.

The region benefits a lot from the local industry, export compliance imposed by regulatory authorities, as well as the high R&D investment in the area.

The major makers of reference compounds in North America are the primary source of a large sale of the compounds to the pharmaceutical and chemical industries

The use of analytical technologies is growing in daily life to achieve many purposes in the lab such as environmental monitoring, drug testing, forensic use, food testing, and so on.

The U.S. and Canada, with high per capita incomes and supportive state policies, are experiencing growth in the market by giving people more access to healthcare services.

The contamination of food is a substantial worldwide health concern, leading to food-borne contagions, allergies, and intoxication.

More than 600 million individuals are affected by food-borne diseases yearly, resulting in around 420,000 demises and 33 million healthy life years lost.

Food-borne diseases cause approximately USD 95 billion in productivity loss in low- and middle-income countries, with global treatment costs reaching around USD 15 billion annually.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by technique
  • 1.4.2. Market size breakdown, by application
  • 1.4.3. Market size breakdown, by methodology
  • 1.4.4. Market size breakdown, by region
  • 1.4.5. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Technique (2017-2030)
• 6.3. Market Revenue, by Application (2017-2030)
• 6.4. Market Revenue, by Methodology (2017-2030)
• 6.5. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Technique (2017-2030)
• 7.3. Market Revenue, by Application (2017-2030)
• 7.4. Market Revenue, by Methodology (2017-2030)
• 7.5. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Technique (2017-2030)
• 8.3. Market Revenue, by Application (2017-2030)
• 8.4. Market Revenue, by Methodology (2017-2030)
• 8.5. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Technique (2017-2030)
• 9.3. Market Revenue, by Application (2017-2030)
• 9.4. Market Revenue, by Methodology (2017-2030)
• 9.5. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Technique (2017-2030)
• 10.3. Market Revenue, by Application (2017-2030)
• 10.4. Market Revenue, by Methodology (2017-2030)
• 10.5. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Technique (2017-2030)
• 11.3. Market Revenue, by Application (2017-2030)
• 11.4. Market Revenue, by Methodology (2017-2030)
• 11.5. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Technique (2017-2030)
• 12.3. Market Revenue, by Application (2017-2030)
• 12.4. Market Revenue, by Methodology (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Technique (2017-2030)
• 13.3. Market Revenue, by Application (2017-2030)
• 13.4. Market Revenue, by Methodology (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Technique (2017-2030)
• 14.3. Market Revenue, by Application (2017-2030)
• 14.4. Market Revenue, by Methodology (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Technique (2017-2030)
• 15.3. Market Revenue, by Application (2017-2030)
• 15.4. Market Revenue, by Methodology (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Technique (2017-2030)
• 16.3. Market Revenue, by Application (2017-2030)
• 16.4. Market Revenue, by Methodology (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Technique (2017-2030)
• 17.3. Market Revenue, by Application (2017-2030)
• 17.4. Market Revenue, by Methodology (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Technique (2017-2030)
• 18.3. Market Revenue, by Application (2017-2030)
• 18.4. Market Revenue, by Methodology (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Technique (2017-2030)
• 19.3. Market Revenue, by Application (2017-2030)
• 19.4. Market Revenue, by Methodology (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Technique (2017-2030)
• 20.3. Market Revenue, by Application (2017-2030)
• 20.4. Market Revenue, by Methodology (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Technique (2017-2030)
• 21.3. Market Revenue, by Application (2017-2030)
• 21.4. Market Revenue, by Methodology (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Technique (2017-2030)
• 22.3. Market Revenue, by Application (2017-2030)
• 22.4. Market Revenue, by Methodology (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Technique (2017-2030)
• 23.3. Market Revenue, by Application (2017-2030)
• 23.4. Market Revenue, by Methodology (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Technique (2017-2030)
• 24.3. Market Revenue, by Application (2017-2030)
• 24.4. Market Revenue, by Methodology (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Technique (2017-2030)
• 25.3. Market Revenue, by Application (2017-2030)
• 25.4. Market Revenue, by Methodology (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Technique (2017-2030)
• 26.3. Market Revenue, by Application (2017-2030)
• 26.4. Market Revenue, by Methodology (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Technique (2017-2030)
• 27.3. Market Revenue, by Application (2017-2030)
• 27.4. Market Revenue, by Methodology (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Technique (2017-2030)
• 28.3. Market Revenue, by Application (2017-2030)
• 28.4. Market Revenue, by Methodology (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Merck KGaA
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Agilent Technologies Inc.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Waters Corporation
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. LGC Standards Ltd.
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. PerkinElmer Inc.
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. SPEX CertiPrep
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. AccuStandard Inc.
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Thermo Fisher Scientific Inc.
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports